- Evaluation of a fixed-dose combination of benazepril and pimobendan in dogs with congestive heart failure: a randomized non-inferiority clinical trial
-
King JN, Hirakawa A, Sonobe J, Otaki H, Sakakibara N, Seewald W, Forster S
- KMID: 2402702
- J Vet Sci.
- 2018 Jan;19(1):117-128.
- doi: 10.4142/jvs.2018.19.1.117
A fixed-dose combination tablet of benazepril and pimobendan (Fortekor Plus; Elanco Animal Health) was tested in dogs with congestive heart failure (CHF) caused by myxomatous mitral valve disease (MMVD) in... -
- CITED
-
- Close
- SHARE
-
- Close
- Genetic background, recent advances in molecular biology, and development of novel therapy in Alport syndrome
-
Nozu K, Takaoka Y, Kai H, Takasato M, Yabuuchi K, Yamamura T, Horinouchi T, Sakakibara N, Ninchoji T, Nagano C, Iijima K
- KMID: 2509802
- Kidney Res Clin Pract.
- 2020 Dec;39(4):402-413.
- doi: 10.23876/j.krcp.20.111
Alport syndrome (AS) is a progressive inherited kidney disease characterized by hearing loss and ocular abnormalities. There are three forms of AS depending on inheritance mode: X-linked Alport syndrome (XLAS), autosomal... -
- CITED
-
- Close
- SHARE
-
- Close
